Deliver Your News to the World

CybeRelease: (OTC: CCRC) Prepares to Launch Dermabrasion Product in the U.S.


(CybeRelease, April 23, 2007) - Lake Harmony, PA - Clinicares Inc. (Other OTC PK: CCRC) announced that it will market its highly acclaimed “micro roller” dermabrasion product in the United States starting next quarter.

Clinicares Micro Roller (CMR) is a new companion in the multi billion-dollar anti-aging industry. It is a non-intrusive alternative to laser dermabrasion and is lauded to be more effective, significantly less expensive and safer than laser dermabrasion. It is also a refreshing alternative to Botox treatment.

The stylish high quality tool is similar in form factor to a shaving razor but with a wheel attached to the end rather than a razor blade. The wheel houses hundreds of tiny surgical steel needles, which float and roll across the skin surface gently, yet penetrating just enough to get the job done. The Roller is used in conjunction with multi-peptide or other topical solutions applied to the skin which when used together invigorate collagen below the skin’s surface.

The result is highly effective in treating wrinkles and scars and other conditions such as pockmarks and so forth. Clinical studies have proven it highly effective. The Clinicares Micro Roller is the result of years of Research and Development by Beverly Hills dermatologists, German engineering, and Korean innovation.

Botox is currently the largest growing anti wrinkle treatment and represents a multi-billion dollar industry unto itself and Clinicares hopes to garner this industry segment and beyond with the Clinicares Micro Roller.

To read the complete release, go to

For a Free Newsletter, go to

CybeRelease Gainers are Factory Card & Party Outlet Corporation (Nasdaq: FCPO), Cambridge Display Technology, Inc. (Nasdaq: OLED), Net.B@nk, Inc. (Nasdaq: NTBK), MDI, Inc. (Nasdaq: MDII), Hub Group, Inc. (Nasdaq: HUBG), Infinity Energy Resources, Inc. (Nasdaq: IFNY), CTI Industries Corporation (Nasdaq: CTIB) and Staktek Holdings, Inc. (Nasdaq: STAK).

CybeRelease Decliners are UAL Corporation (Nasdaq: UAUA), ev3 Inc. (Nasdaq: EVVV), RightNow Technologies, Inc. (Nasdaq: RNOW), Inc. (Nasdaq: STMP), Avici Systems Inc. (Nasdaq: AVCI), Movie Gallery, Inc. (Nasdaq: MOVI), Hanmi Financial Corporation (Nasdaq: HAFC) and Antigenics Inc. (Nasdaq: AGEN).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for informational purposes only and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.